Loading Valuation Snapshot...
Stock DNA
Medical Equipment/Supplies/Accessories
INR 8 Cr (Micro Cap)
NA (Loss Making)
53
0.00%
-0.41
-24.00%
7.85
Revenue and Profits (1 Year):
Net Sales:
(Quarterly Results - )
Net Profit:
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
4.83%
0%
4.83%
1 Year
-51.75%
0%
-51.75%
2 Years
16.6%
0%
16.6%
3 Years
30.14%
0%
30.14%
4 Years
20.62%
0%
20.62%
5 Years
42.96%
0%
42.96%
Transpact Enter. for the last several years.
Risk Adjusted Returns v/s Sensex 
Returns Beta
Beta has not been calculated since enough price history is not available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
53
Price to Book Value
7.85
EV to EBIT
-7.44
EV to EBITDA
-7.44
EV to Capital Employed
7.44
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-10.00%
ROE (Latest)
-24.00%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Sep 2024
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Raman Talwar (16.03%)
Highest Public shareholder
Consolidated Speciality Services (6.46%)
Individual Investors Holdings
54.35%
Half Yearly Results Snapshot (Standalone) - Sep'24
Sep'24
Mar'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.03
-0.02
-50.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.05
-0.06
16.67%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales
Growth in half year ended Sep 2024 is 0.00% vs 0.00% in Mar 2024
Standalone Net Profit
Growth in half year ended Sep 2024 is 16.67% vs -100.00% in Mar 2024
Annual Results Snapshot (Standalone) - Mar'24
Mar'24
Mar'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.06
-0.14
57.14%
Interest
0.00
0.00
Exceptional Items
0.00
0.08
-100.00%
Standalone Net Profit
-0.09
-0.07
-28.57%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2024 is 0.00% vs -100.00% in Mar 2023
Standalone Net Profit
YoY Growth in year ended Mar 2024 is -28.57% vs 70.83% in Mar 2023
About Transpact Enterprises Ltd 
Transpact Enterprises Ltd
Micro Cap
Medical Equipment/Supplies/Accessories
Transpact Enterprises Limited was incorporated as a Private Limited Company with the name "Transpact Enterprises Private Limited" on May 12, 2013. Further, the status of the Company was changed to a Public Limited Company and the name of the Company was changed to "Transpact Enterprises Limited" and a fresh Certificate of Incorporation was granted to the Company on April 16, 2019 by the Registrar of Companies, Mumbai. The Company is the first start-up to get listed on the BSE Startup Platform.
Company Coordinates 
No Company Details Available